Literature DB >> 27173681

Prolonged Tp-e interval and Tp-e/QT correlates well with modified Rodnan skin severity score in patients with systemic sclerosis.

Sercan Okutucu1, Ugur Nadir Karakulak, Hakan Aksoy, Cengiz Sabanoglu, Vedat Hekimsoy, Levent Sahiner, Ergun Baris Kaya, Ali Akdogan, Giray Kabakci, Kudret Aytemir, Lale Tokgozoglu, Ali Oto.   

Abstract

BACKGROUND: Ventricular arrhythmias can be seen in systemic sclerosis (SSc) patients and are thought to be a result of fibrosis or ischemia of the ventricular myocardium. Tp-e interval and Tp-e/QT ratio are electrocardiographic (ECG) indices to predict ventricular tachyarrhythmia and cardiovascular mortality. We aimed to evaluate Tp-e interval and Tp-e/QT ratio in patients with SSc.
METHODS: A total of 107 patients with SSc (mean age, 48.6 ± 14.0 years; 96 females) and 100 healthy controls (mean age, 49.4 ± 8.6 years; 90 females) were enrolled. The standard 12-lead ECG was recorded; QTc, Tp-e interval and Tp-e/QT ratio were measured. Modified Rodnan skin severity score (MR-SSS) calculated for all SSc patients.
RESULTS: Tp-e interval (90.7 ± 23.8 ms vs. 84.0 ± 20.6 ms, p = 0.032) and Tp-e/QT ratio (0.20 ± 0.05 vs. 0.18 ± 0.04, p = 0.007, respectively) were significantly prolonged in SSc patients than in the control group. Pearson's correlation analyses revealed positive correlations of MR-SSS with QTc (r = 0.427, p = 0.001), Tp-e interval (r = 0.620, p = 0.001) and Tp-e/ /QT ratio (r = 0.615, p = 0.001). MR-SSS (b = 2.108, p = 0.001) and CRP (b = 2.273, p = 0.027) were found to be significant independent predictors of Tp-e interval. Similarly, MR-SSS (b = 0.004, p = 0.001) was only a significant independent predictor of Tp-e/QT ratio among patients with SSc.
CONCLUSIONS: The patients with SSc had a prolonged Tp-e interval and Tp-e/QT ratio compared with normal subjects. Furthermore, this prolongation was well correlated with clinical severity score among patients with SSc. Ventricular repolarization dispersion as a predictor of ventricular arrhythmias was found to be diminished in patients with SSc. Patients with SSc, particularly with higher MR-SSS, should be followed closely for adverse cardiovascular outcomes.

Entities:  

Keywords:  Tp-e interval; Tp-e/QT ratio; systemic sclerosis

Mesh:

Year:  2016        PMID: 27173681     DOI: 10.5603/CJ.a2016.0021

Source DB:  PubMed          Journal:  Cardiol J        ISSN: 1898-018X            Impact factor:   2.737


  7 in total

1.  Effects of SGLT2 Inhibitors as an Add-on Therapy to Metformin on Electrocardiographic Indices of Ventricular Repolarization.

Authors:  Mustafa Duran; Murat Ziyrek; Yakup Alsancak
Journal:  Acta Cardiol Sin       Date:  2020-11       Impact factor: 2.672

2.  Repolarization in systemic sclerosis: a meta-analysis.

Authors:  Yehuda Wexler; Udi Nussinovitch
Journal:  Clin Rheumatol       Date:  2021-11-29       Impact factor: 2.980

Review 3.  T-Wave Indices and Atherosclerosis.

Authors:  Gary Tse; George Bazoukis; Leonardo Roever; Tong Liu; William K K Wu; Martin C S Wong; Adrian Baranchuk; Panagiotis Korantzopoulos; Dimitrios Asvestas; Konstantinos P Letsas
Journal:  Curr Atheroscler Rep       Date:  2018-09-17       Impact factor: 5.113

4.  Diffuse cardiac fibrosis quantification in early systemic sclerosis by magnetic resonance imaging and correlation with skin fibrosis.

Authors:  Daniel C Lee; Monique E Hinchcliff; Roberto Sarnari; Madeline M Stark; Jungwha Lee; Kimberly Koloms; Aileen Hoffmann; Mary Carns; Anjali Thakrar; Kathleen Aren; John Varga; Alejandro Aquino; James C Carr; Brandon C Benefield; Sanjiv J Shah
Journal:  J Scleroderma Relat Disord       Date:  2018-04-12

5.  Increased dermal collagen bundle alignment in systemic sclerosis is associated with a cell migration signature and role of Arhgdib in directed fibroblast migration on aligned ECMs.

Authors:  Lizhi Cao; Robert Lafyatis; Linda C Burkly
Journal:  PLoS One       Date:  2017-06-29       Impact factor: 3.240

6.  Electrocardiographic markers for the prediction of ventricular arrhythmias in patients with systemic sclerosis.

Authors:  Veronika Sebestyén; Gabriella Szűcs; Dénes Páll; Dóra Ujvárosy; Tamás Ötvös; Imre Csige; Tamás Pataki; István Lőrincz; Zoltán Szabó
Journal:  Rheumatology (Oxford)       Date:  2020-03-01       Impact factor: 7.580

Review 7.  Sclerodermic Cardiomyopathy-A State-of-the-Art Review.

Authors:  Adrian Giucă; Tea Gegenava; Carmen Marina Mihai; Ciprian Jurcuţ; Adrian Săftoiu; Diana Monica Gȋrniţă; Bogdan Alexandru Popescu; Nina Ajmone Marsan; Ruxandra Jurcuț
Journal:  Diagnostics (Basel)       Date:  2022-03-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.